These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37843374)

  • 1. Characterization and biodistribution of under-employed gene therapy vector AAV7.
    Yost SA; Firlar E; Glenn JD; Carroll HB; Foltz S; Giles AR; Egley JM; Firnberg E; Cho S; Nguyen T; Henry WM; Janczura KJ; Bruder J; Liu Y; Danos O; Karumuthil-Melethil S; Pannem S; Yost V; Engelson Y; Kaelber JT; Dimant H; Smith JB; Mercer AC
    J Virol; 2023 Nov; 97(11):e0116323. PubMed ID: 37843374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of the Capsid Structures of AAVrh.10, AAVrh.39, and AAV8.
    Mietzsch M; Barnes C; Hull JA; Chipman P; Xie J; Bhattacharya N; Sousa D; McKenna R; Gao G; Agbandje-McKenna M
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coevolution of Adeno-associated Virus Capsid Antigenicity and Tropism through a Structure-Guided Approach.
    Havlik LP; Simon KE; Smith JK; Klinc KA; Tse LV; Oh DK; Fanous MM; Meganck RM; Mietzsch M; Kleinschmidt J; Agbandje-McKenna M; Asokan A
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy.
    Gao GP; Alvira MR; Wang L; Calcedo R; Johnston J; Wilson JM
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11854-9. PubMed ID: 12192090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Study of Aavrh.10 Receptor and Antibody Interactions.
    Mietzsch M; Yu JC; Hsi J; Chipman P; Broecker F; Fuming Z; Linhardt RJ; Seeberger PH; Heilbronn R; McKenna R; Agbandje-McKenna M
    J Virol; 2021 Nov; 95(23):e0124921. PubMed ID: 34549984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K137R mutation on adeno-associated viral capsids had minimal effect on enhancing gene delivery in vivo.
    Qiao C; Li C; Zhao C; Li J; Bian T; Grieger J; Li J; Samulski RJ; Xiao X
    Hum Gene Ther Methods; 2014 Feb; 25(1):33-9. PubMed ID: 24116972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.
    Lam AK; Frabutt D; Li L; Xiao W
    Hum Gene Ther; 2021 Dec; 32(23-24):1433-1438. PubMed ID: 34254844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan Sulfate Binding Promotes Accumulation of Intravitreally Delivered Adeno-associated Viral Vectors at the Retina for Enhanced Transduction but Weakly Influences Tropism.
    Woodard KT; Liang KJ; Bennett WC; Samulski RJ
    J Virol; 2016 Nov; 90(21):9878-9888. PubMed ID: 27558418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping an Adeno-associated Virus 9-Specific Neutralizing Epitope To Develop Next-Generation Gene Delivery Vectors.
    Giles AR; Govindasamy L; Somanathan S; Wilson JM
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30089698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted modifications in adeno-associated virus serotype 8 capsid improves its hepatic gene transfer efficiency in vivo.
    Sen D; Gadkari RA; Sudha G; Gabriel N; Kumar YS; Selot R; Samuel R; Rajalingam S; Ramya V; Nair SC; Srinivasan N; Srivastava A; Jayandharan GR
    Hum Gene Ther Methods; 2013 Apr; 24(2):104-16. PubMed ID: 23442071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation Targets Adeno-associated Virus Capsids but Mainly Restricts Transduction by Cellular Mechanisms.
    Chen Q; Njenga R; Leuchs B; Chiocca S; Kleinschmidt J; Müller M
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of the AAVhu.37 capsid by cryoelectron microscopy.
    Kaelber JT; Yost SA; Webber KA; Firlar E; Liu Y; Danos O; Mercer AC
    Acta Crystallogr F Struct Biol Commun; 2020 Feb; 76(Pt 2):58-64. PubMed ID: 32039886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.
    Ballon DJ; Rosenberg JB; Fung EK; Nikolopoulou A; Kothari P; De BP; He B; Chen A; Heier LA; Sondhi D; Kaminsky SM; Mozley PD; Babich JW; Crystal RG
    Hum Gene Ther; 2020 Dec; 31(23-24):1237-1259. PubMed ID: 33233962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Serpentine Adeno-Associated Virus (SAAV) Capsid Structure: Receptor Interactions and Antigenicity.
    Mietzsch M; Hull JA; Makal VE; Jimenez Ybargollin A; Yu JC; McKissock K; Bennett A; Penzes J; Lins-Austin B; Yu Q; Chipman P; Bhattacharya N; Sousa D; Strugatsky D; Tijssen P; McKenna R; Agbandje-McKenna M
    J Virol; 2022 Jun; 96(11):e0033522. PubMed ID: 35532224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors.
    Boutin S; Monteilhet V; Veron P; Leborgne C; Benveniste O; Montus MF; Masurier C
    Hum Gene Ther; 2010 Jun; 21(6):704-12. PubMed ID: 20095819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein.
    Mori S; Wang L; Takeuchi T; Kanda T
    Virology; 2004 Dec; 330(2):375-83. PubMed ID: 15567432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution.
    Grimm D; Büning H
    Hum Gene Ther; 2017 Nov; 28(11):1075-1086. PubMed ID: 28835125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.
    Liu Y; Zhang X; Yang L
    Curr Gene Ther; 2020; 20(5):321-332. PubMed ID: 32998676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV Capsid.
    Martino RA; Wang Q; Xu H; Hu G; Bell P; Arroyo EJ; Sims JJ; Wilson JM
    J Virol; 2023 Jun; 97(6):e0017423. PubMed ID: 37199615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.